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Abstract
This review discusses the evidence linking industrial chemicals to a variety of health and 
reproductive outcomes is discussed. Industrial chemical production has increased over the last 30–
40 years. Basic science, animal models, and epidemiologic data suggest that certain chemicals 
may act as endocrine disruptors (substances which interfere with normal hormonal action) and 
may play an etiologic role in a number of conditions whose incidence has also increased during 
this same period. These include low birth weight, gestational diabetes, obesity, certain cancers, 
certain birth defects, and neurodevelopmental disorders such as attention deficit disorder and 
autism. In addition, some environmental chemicals may have epigenetic effects, resulting in 
transgenerational health impacts. The epidemiologic and experimental evidence that links 
chemicals such as plasticizers such as phthalates and phenols, flame retardants, perfluorinated 
compounds, and pesticides, with adverse reproductive health outcomes is reviewed. Women’s 
health care providers are the liaison between scientific research and their patients; they should 
educate themselves on the significance to health of environmental toxins. They are ideally 
positioned, not only to counsel and reassure pregnant women, but to suggest practicable changes 
in dietary and lifestyle habits to improve their health. Furthermore, women’s health care providers 
should advocate for regulatory changes that protect women and their families from the health 
effects of environmental toxins.
Précis
This paper reviews the adverse effects of endocrine-disrupting chemicals on reproductive health 
and outlines patient counseling and advocacy points for clinicians.
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INTRODUCTION
Modern living has spurred the increasing production of industrial chemicals over the last 30 
to 40 years (N.J Morin, PhD, Assistant Director and Chief, Industrial Output Section, 
Division of Research and Statistics, Federal Reserve Board, written communication, 
February 2016), resulting in the current manufacture, or importation into the United States, 
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of an estimated 30,000 pounds per person of these substances per year.1 Exposure to 
industrial chemicals occurs through air and water pollution, contamination of the food chain, 
and consumer products.2 In fact, a sampling of pregnant women in the United States showed 
that virtually every study subject had in her bloodstream at least 43 different environmental 
chemicals, including certain polychlorinated biphenyls, organochlorine pesticides, 
perfluorinated compounds, phenols, polybrominated diphenyl ethers, phthalates, polycyclic 
aromatic hydrocarbons, and perchlorate.3 Over the last 30 years, the rates of many 
noncommunicable diseases, including obesity, diabetes, infertility, asthma, autism, attention 
deficit hyperactivity disorder, certain birth defects, childhood cancers, and cancers of the 
breast and reproductive tract have increased.4 Although it is very likely that these increases 
are multifactorial, there is legitimate concern that exposure to industrial chemicals and other 
environmental toxins, especially those that affect endocrine function, plays a significant role.
2,5–7
 The purpose of this paper is to provide an overview of the adverse effects of endocrine-
disrupting chemicals on women’s reproductive health, and offer clinicians some talking 
points for patient counselling and advocacy.
EVALUATING THE IMPACT OF CHEMICALS ON WOMEN’S HEALTH: ISSUES AND 
METHODOLOGY
Studying the impact of environmental chemicals on human health is complicated by several 
issues. Randomized controlled trials to conclusively establish the harms of specific 
chemicals would not be ethical. Without this preferred level of evidence, we must use animal 
or basic science models, in addition to epidemiologic data. Environmental exposures and 
their outcomes can be hard to assess. This is multifactorial: exposure to chemicals is 
typically not documented outside of industrial settings, and different people have different 
levels of sensitivity (stemming from nutritional status, life stage, metabolism, or genetics).7 
Additionally, the particular chemical involved may not be identifiable, even if an exposure 
was known to occur. The timing of exposure may be unclear or have occurred in the distant 
past. In the absence of human experimental data, the best evidence comes from consistent 
health effects in experimental animal models and human epidemiologic data.2
A new methodology, named Navigation Guide,8 provides a systematic approach to 
synthesizing data from in vitro, experimental animal, and any available human studies. Its 
key elements are modeled after the Cochrane and Grading of Recommendations, 
Assessment, Development, and Evaluation (GRADE) methodologies of systematic reviews 
in clinical medicine. These elements include a pre-specified protocol for selecting and rating 
the strength of the evidence, standardized and transparent documentation including expert 
judgment, a comprehensive search strategy, and assessment of “risk of bias,” with the goal 
of minimizing subjectivity and bias while maximizing transparency and consistency.8 There 
are only a few topics with published Navigation Guide systematic reviews,9–11 as the 
method is new and time-intensive, but it is anticipated to elevate the standard of evidence 
assessment in environmental health research.8
Despite the challenges to obtaining proof that specific chemicals are harmful, enough 
circumstantial data has been amassed to concern many in the scientific community. 
Professional organizations, including the American Academy of Pediatrics, the Association 
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of Women’s Health Obstetric, & Neonatal Nurses, the American College of Nurse-
Midwives, and the American College of Obstetricians and Gynecologists, have joined the 
voices calling for attention to these concerns. Recommendations by these bodies are found 
in Table 1. There is consensus that women’s health care providers should advocate for 
policies to prevent exposure to toxic environmental chemicals, as well as provide health care 
that includes education about, interventions to prevent, and addresses the consequences of, 
reproductive environmental toxins.
KEY CONCEPTS: ENDOCRINE-DISRUPTING CHEMICALS AND WINDOWS OF SENSITIVITY
An endocrine-disrupting chemical (EDC) is any substance that interferes with normal 
hormonal activity. The category includes some metals, many industrial chemicals, natural 
and synthetic hormones, pesticides, fungicides, herbicides, and pharmaceutical drugs; even 
personal care products may incorporate EDCs. In some cases, EDCs bind to the receptor for 
a natural hormone (for example, bisphenol A [BPA] can bind to the estrogen receptor).18 
Thus bound, an EDC can act as an agonist and activate the receptor in the same way as the 
normal ligand, or the EDC can bind to the receptor as an antagonist, and turn off the normal 
hormonal action of the receptor.7 Alternatively, EDCs can interact with hormonal pathways, 
bypassing the receptor and activating or inactivating second messenger systems, or 
interfering with gene activation, or by changing levels of hormone-binding proteins.7 To 
further complicate the scientific study of EDCs, some may act in multiple ways, depending 
on dose, tissue type, and sex.2,18
The timing of endocrine disruption during the individual lifespan is often important; there 
are windows of varying susceptibility, including during embryogenesis in early pregnancy as 
well as throughout fetal life, infancy, childhood, and adolescence.5,18 Some periods of 
susceptibility result from rapid cell growth or differentiation; some are due to enhanced 
hormonal responsivity.2 Pharmaceutical teratogens, for the most part, have their greatest 
impact during the first trimester, and ionizing radiation and lead poisoning are of greatest 
concern in young infants and children. Adolescence may be a time of increased sensitivity to 
endocrine promoters of cancers of the breast.2 Awareness of these windows of susceptibility 
should alert women’s health care providers to the importance of protecting reproductive-
aged women from toxins that might have an impact upon their future health or fertility, as 
well as that of a future fetus, a current fetus, or a breast-feeding child.
The concern about EDCs and reproduction is heightened by emerging evidence suggesting 
that some toxins may have impacts that extend beyond the first generation. 
Multigenerational effects of EDCs were first established with the pharmaceutical estrogen 
diethylstilbestrol (DES). Daughters whose mothers took DES during pregnancy have a 
higher risk of several adverse reproductive outcomes, including rare vaginal cancers and 
cervical incompetence.19 The grandsons of women who took DES in pregnancy appear to 
have a higher risk of hypospadias, suggesting that EDCs can cause transgenerational effects 
through epigenetic mechanisms.20 Although other established human examples of 
transgenerational impacts of EDCs are rare, animal models predict we may see 
transgenerational effects of some EDCs in the future.2,5
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Specific Examples of Endocrine-Disrupting Chemicals with Effects on Reproduction
Bisphenol A.—Bisphenol A, or BPA, an artificial estrogen developed by the same chemist 
who developed diethylstilbestrol,21 is produced worldwide at a rate of greater than 5 billion 
pounds per year.22 BPA’s phenyl groups mimic estrogen and can bind to the estrogen 
receptor.2 Animal and basic science experiments show that BPA can act as an estrogen 
agonist as well as an estrogen antagonist.6 Human epidemiologic data suggest that BPA acts 
in humans as an estrogen agonist as well.6 BPA has also shown “obesogenic” properties in 
animal models.2
Emerging data suggest that BPA can interfere with normal fetal neurodevelopment. A cohort 
study of 240 children published by Braun and colleagues23 in 2011 explored the association 
of fetal exposure to BPA, as measured by maternal urinary samples (collected at ~16 and 
~26 weeks’ gestation and at birth) and childhood behavioral outcomes at age 3. Outcomes 
were measured by the Behavior Assessment System for Children 2 (BASC-2) Parent Rating 
Scale for preschoolers and the Behavior Rating Inventory of Executive Function-Preschool 
(BRIEF-P), both of which are validated parent-report inventories of behaviors in community 
and home settings. In this study, fetal BPA exposure was associated with increased anxiety, 
depressive symptoms, and impaired behavioral regulation at age 3, and this finding was 
worse for girls than for boys.23 The size of the effect measured was clinically significant (eg, 
for anxiety in girls, an increase in BPA level from the 10th to the 90th percentile was 
associated with an increase in anxiety score from the 30th to the 86th percentile). The 
validity of these results may be affected by unmeasured confounding, although the authors 
controlled for mother’s race, education, marital status, household income, tobacco use, and 
maternal depression.23
BPA has also been shown to interfere with male reproduction.6 An occupational cohort 
study in China compared workers in BPA factories (n=164) with factory workers not 
exposed to BPA (n=386). The BPA-exposed workers had a reduced frequency of intercourse, 
increased ejaculatory dysfunction, reduced satisfaction with their sex life, reduced sex drive, 
and reduced ability to have an erection. In the study, the average urinary BPA level was 58 
micrograms per gram of creatinine versus 1.2 micrograms per gram of creatinine for the 
unexposed workers.24 Of note, since these were occupational exposures, the subjects had 
higher BPA levels than would typical consumers.
Phthalates.—Phthalates are another class of chemicals25 that have been implicated as 
endocrine disrupters.7 Phthalates are used in multiple consumer applications, including 
personal care products such as lotion or shampoo, often as “fragrance”, and as plasticizers to 
change the physical characteristics of base plastics, including products made with polyvinyl 
chloride, such as flooring, shower curtains, packaging, and some medical equipment.25 
Human cohort and experimental animal studies have demonstrated possible adverse effects 
on reproduction, including associations with poor semen quality and miscarriage.26,27 
Prenatal phthalate exposure, as measured by phthalate metabolite levels in maternal urine, 
has been associated with abnormal male genital development in the fetus. In animal models, 
anogenital distance is a sensitive index of demasculinization of the male reproductive tract. 
Multiple epidemiologic studies, including prospective cohort studies, have shown a 
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shortened anogenital distance (suggesting anti-androgenic influence) in boys whose mothers 
had higher urinary phthalate levels during pregnancy.28,29 Some cohort studies have shown 
an association with smaller penile size as well.30 These findings are reproducible in 
experimental studies with rodents.31
Prenatal phthalate exposure has also been associated with reduced “masculine play” in boys, 
as indicated in a follow-up study of a cohort of couples who had given blood and urine 
samples during pregnancy. At age 5, the boys’ (n=74) play activities were assessed with a 
validated inventory of play styles (Pre-School Activities Inventory). An association was seen 
between prenatal exposure to anti-androgenic phthalates and less male-typical play behavior 
in boys.
The masculine play score dropped by 8% if a boy’s mother’s prenatal urinary phthalate 
metabolite concentration increased from the 10th percentile to the 90th percentile.32 No 
effect was seen in the girls studied.32 (The importance and validity of such measures as 
“masculine play score” should be interrogated elsewhere.) In another multicenter cohort 
study, long-term follow up of 163 children revealed higher maternal prenatal urine 
concentrations of monoisobutyl phthalate were associated with worse scores on several 
parent-reported behavioral measures for their sons at ages 6 to 10, including inattention, 
rule-breaking behavior, aggression, and conduct problems. No statistically significant effect 
was seen in girls.33 A recent systematic review of 11 human studies suggests that higher 
levels of prenatal exposure to phthalate metabolites, measured as urinary concentrations, are 
associated with poorer cognitive and behavioral outcomes in children, especially boys.34 
These studies were all observational, so unmeasured confounding cannot be excluded, 
although most of the studies controlled for confounders such as age, gender, birth weight, 
history of breastfeeding, race, socioeconomic status, and maternal IQ or educational level.34
Phthalate exposure may also directly harm maternal health.2 In a secondary analysis of a 
prospective cohort prenatal phthalate-exposure study, mono-benzyl phthalate (a metabolite 
of a high-molecular-weight phthalate, benzylbutyl phthalate, found in adhesives, sealants, 
vinyl tile, and possibly some personal care products25) concentrations were significantly 
associated with higher maternal diastolic blood pressure at <20 weeks gestation, with dose-
response associations for systolic and diastolic blood pressures.35 Additionally, of the 369 
women studied, those in the top tercile of mono-benzyl phthalate at 16 weeks had an 
increased risk of developing pregnancy-induced hypertensive disorders (clinical diagnoses of 
gestational hypertension, preeclampsia, eclampsia, or HELLP syndrome).35
Flame retardants.—Flame retardants are another class of chemicals with suspected 
reproductive toxicity. Polybrominated diphenyl ethers (PBDEs) have been used extensively 
in foam and plastics to meet ignition standards in the United States, and they have been 
found in pregnant women’s blood3 and in cord blood.38Although some PDBEs have been 
taken off the market, they are persistent in humans and the environment.19 Prenatal exposure 
to PBDEs was associated with adverse neurodevelopmental outcomes in offspring in a 
hypothesis-generating cohort study of 175 children.36 In another cohort study of over 300 
mothers and their children, higher maternal serum PBDE concentrations in the third 
trimester were associated with impaired attention at age 5 and poorer fine motor 
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coordination at ages 5 and 7. In addition, the study noted decrements in the IQ of offspring 
at age 7, as measured on validated neurobehavioral assessments completed by parents, 
teachers, and psychometricians.37 In another longitudinal cohort study (n=210), children 
with higher cord blood concentrations of PDBEs scored lower on tests of mental and 
physical development, including the Bayley Scales of Infant Development and the Wechsler 
Preschool and Primary Scale of Intelligence.38 The mechanisms by which PBDEs affect 
these outcomes are a subject of ongoing study, but endocrine disruption is suspected as a 
possible cause. PBDEs are thought to interact with steroid hormone receptors, and also to 
suppress normal thyroid hormone function.39 Given that precisely regulated thyroid 
hormonal activity is implicated in normal fetal brain development,40 these interactions may 
have a causal role in abnormal neurodevelopment. Similar neurodevelopmental 
abnormalities are seen in prenatally exposed mouse experimental models.39,41
Perfluorinated Compounds.—Yet another group of chemicals suspected to have 
reproductive effects are the perfluorinated compounds (PFCs),2 which include a number of 
chemicals used for waterproofing, stain resistance, and lubrication, and include 
perfluorooctane sulfonate, perflurooctanoic acid, and perfluorohexane sulfonate. Some PFCs 
are found in food packaging and nonstick cookware.42 Exposure has been associated with 
adverse health outcomes. In particular, increasing concentrations of perfluorooctanoic acid 
and certain other PFCs in maternal plasma were associated with reduced fecundity and 
infertility in a Canadian cohort of 1743 women.43 Prenatal perfluorooctanoic acid exposure 
has also been associated with poor fetal growth in a number of experimental animal and 
human cross-sectional studies, confirmed by the Navigation Guide methodology.9,10,44 How 
PFCs act as endocrine disruptors is an area of active study. Animal models and in vitro 
studies show interactions with estrogen-and androgen-receptors, thyroid hormones, and 
neurotransmitters.2,45 In humans, PFC concentrations have been associated with alterations 
in thyroid function.45
Pesticides.—Pesticides have long been implicated in adverse reproductive outcomes.46 
The scope of pesticides with potential to disrupt endocrine systems is broad, and has been 
reviewed elsewhere.7,47 In one example study, measurements of IQ at ages 5–7 were 
associated with fetal organophosphate pesticide exposure in a prospective cohort of 260 
children. The difference between the highest and lowest quintiles of exposure was equivalent 
to 7 full-scale IQ points. The results were robust to adjustment for confounding by maternal 
age, intelligence and education level, breast-feeding duration, birth order, socioeconomic 
status, and marital status.48
Other sources of endocrine-disrupting chemicals.—It is beyond the scope of this 
paper to mention, much less describe in detail, all of the substances that are suspected 
endocrine disruptors. Air, water, and soil carry not only endocrine disruptors and other 
manufactured chemicals but also “natural” substances (such as arsenic or methane) that in 
unnatural situations may affect health.2 Recent concern by the popular media and some 
scientists has focused on the health risks associated with a new oil and gas exploration 
technique (“fracking”). The handful of published studies that explore the effects of fracking 
on reproduction include research on pregnancy and proximity to fracking wells and have 
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identified varying associations with preterm birth and low birth weight.49,50 Basic science 
studies, including in vitro cell culture assays and experimental studies in mice, have 
suggested that certain fracking chemicals may be endocrine disrupters.51 These data are 
preliminary, but some health professionals have urged caution in the expansion of fracking 
to new sites.52
COMMUNICATING RISKS OF ENDOCRINE-DISRUPTING CHEMICALS
Preliminary questions
Answering the question of what to tell women about EDCs requires answers to several 
preliminary questions: What do women want to know, and how have we succeeded in 
responding to their requests? What can we tell them (ie, what do we know about EDCs and 
other environmental toxins?) And, last, how can we best go about conveying good 
information?
What do women want to know?—Biomonitoring and survey research studies provide 
some guidance on the information women want and need. Some women are unaware of the 
hazards of environmental toxins,53,54 and some worry about potential toxins, but don’t trust 
the resources they find in the public sphere. Furthermore, many find that their medical 
providers are not discussing these concerns.53 Studies of both pregnant women and women 
in biomonitoring cohorts have shown that women want information on personal exposures to 
environmental chemicals, and they believe they have the right to know.55 Moreover, one 
study found that 97% wanted exposure information even if the health implications of the 
information were unclear.56 Respect for patients’ autonomy should prompt women’s health 
care providers to share their knowledge of the harms of endocrine-disrupting chemicals with 
those at risk.55
Given these study results, how well have we done in communicating risk to patients? First, it 
is undeniable that until recently, there has been less than optimal awareness, knowledge, or 
interest, among both health care providers and the public, on the everyday ubiquity of the 
chemicals under discussion here. Environmental health has only infrequently been a topic of 
discussion during routine health care. A mixed methods study of obstetricians’ reticence to 
engage in such discussions by Stotland and colleagues57 revealed two main themes: “bigger 
fish to fry,” namely, other clinical or health concerns of higher priority than environmental 
concerns; and “Pandora’s box,” meaning discomfort with the possibility that the subject of 
environmental concerns may provoke questions for which these physicians have no answers.
57
 Some providers worry about putting the burden of avoiding toxins on already stressed 
(and caffeine-, wine-, sushi-, and turkey-deprived) pregnant women.57 Midwives’ attitudes 
toward discussing environmental health with patients have not been explicitly studied. It is 
plausible that similar issues of competing clinical priorities, time limitations, and gaps in the 
evidence base are also barriers to midwives’ counseling of women.
What should women be told?—The studies and evidence cited above document both 
the extent of our knowledge about EDCs and some of the lacunae. This information is useful 
only if and when it is mastered by health care providers. Informing ourselves precedes 
informing others. For providers grappling with how to communicate risks without causing 
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undue worry, it is useful to remember that the effects of these chemicals generally subtle, 
and that not everyone will be susceptible, such that often an effect is only clearly seen on 
population level. For a given toxin, if studies show a difference of 2–5 IQ points’ difference 
based on an exposure, the impact on an individual is likely to be minimal. The additive 
impact, however, on a society comprised of individuals with slightly lower IQs, is 
significant. Another fact that may help to put this information into perspective for worried 
women: the exposures discussed in this review may have effects similar to that seen with a 
childhood lead level of 5 mcg/dl, now considered elevated, but which would have been much 
lower than the levels seen in the late 1970s when the median was 15 mcg/dl.4
Conveying good information—The first step might be establishing an environmental 
history for each individual patient. Table 2 is a suggested form, adapted from The Great 
Lakes Center for Children’s Environmental Health, which provides not only an assessment 
of the patient’s risk for use by both the health care provider and the patient herself, but also 
suggestions for making healthful choices. Taking an environmental history (see Appendix 
for a link to other suggested history forms) is a way of assessing patients’ knowledge, toxin 
exposure risk, and concerns. Taking an environmental history from some women may reveal 
that they are not interested in change, or that their exposures are systemic and not easily 
addressed.
Nevertheless, for those women and their families who are eager and able to take personal 
action, studies show that individual-level actions can make a difference. A few experimental 
trials have shown decreased body burdens of specific chemicals in response to specific 
behavioral modifications such as dietary changes. In one crossover study, which took place 
in the cafeteria at the Harvard School of Public Health, two groups of volunteers were served 
5 days of either fresh or canned soup and then five days of the other soup. Urinary bisphenol 
A levels were measured at the end of each period and were significantly lower when the 
subjects were served fresh soup.58 Another study followed five Bay Area families over 
several days during which they ate their usual diet, and then were served three days of 
catered fresh organic food, without any exposure to BPA or plastics. This study also showed 
lower urinary BPA levels.59 Similar studies have shown the effect of eating a diet of organic 
produce, with lowered urinary or serum levels of pesticides during consumption of organic 
rather than conventional produce.60 These studies suggest that dietary changes (consuming 
fresh organic food, avoiding canned food) can lower exposure to BPA and pesticides. Of 
note, although women can be counseled based on the current evidence base, the potential for 
unintended consequences exists.64 For example, if women choose water bottles made with 
“BPA-free” plastic in an attempt to avoid EDCs, they may inadvertently expose themselves 
to BPA replacements such as bisphenol S or bisphenol X, which are also thought to be 
EDCs.65
There is a caveat, however: no randomized controlled trials have been published to establish 
that any given personal action, such as eating fresh soup, will improve pregnancy outcomes. 
Until these data exist, however, the precautionary principle, which states that “when the 
health of humans and the environment is at stake, it may not be necessary to wait for 
scientific certainty to take protective action,” suggests that actions based on the available 
literature may improve outcomes. Women ask for advice on avoiding environmental toxins, 
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and hope their clinicians will provide some guidance53 even if clinicians do not have all the 
answers.55 Table 3 provides some guidance on ways to avoid endocrine-disrupting 
chemicals, based on studies in humans and animals, as well as in vitro. The ability to avoid 
exposures to EDCs may be limited by a woman’s socioeconomic circumstances, but many 
proposed steps are free or low cost and will be available to most women (washing hands 
prior to eating,61–63 avoiding soda,58,59 not microwaving in plastic,63,66 limiting use of 
personal care products62). Additionally, a number of the recommended steps are often 
promoted for other health indications (washing hands prior to eating, limited processed 
foods and those high in animal fat, vacuuming house dust), and are expected to decrease 
exposures to other industrial and environmental chemicals which may be identified as 
endocrine disruptors in the future.67
Addressing special situations—Although many patient exposures are easy to address 
with the above steps, some situations require more urgent detoxification or complex care. If 
a patient has occupational or home exposures to lead, mercury, pesticides, or other 
chemicals, or questions that the provider cannot answer, the Appendix lists several resources 
and websites which have more in depth information available. The Program in Reproductive 
Health and the Environment (PRHE) at the University of California San Francisco has a 
series of educational brochures, including one called “Work Matters” that includes resources 
for addressing occupational exposures. PRHE’s website also contains links to a number of 
resources for clinicians, including environmental health history forms.
Another valuable resource is the network of regional Pediatric Environmental Health 
Specialty Units (PEHSUs), distributed in the ten regions of the Environmental Protection 
Agency (EPA). This network was established in 1998, with the units based at academic 
centers throughout the country. The PEHSUs are jointly funded by the Agency for Toxic 
Substances and Disease Registry of the CDC (Centers for Disease Control and Prevention) 
and the EPA, and provide consultations with pediatric experts in environmental health and 
toxins. Since 2015, PEHSUs have included reproductive health experts on their staff. Other 
resources, noted in the Appendix, include occupational medicine specialists and 
toxicologists, in addition to the Occupational Safety and Health Administration. The Agency 
for Toxic Substances and Disease Registry, in conjunction with the PEHSUs, is creating an 
application for clinicians that will have a search function for obtaining information on 
environmental toxins.
The immovable bottom line, when knowledge, history, remedies, and resources are added 
up, is that the counsel offered to women by their health care providers must be a 
combination of sensitivity to the needs and abilities of each woman as well as a measure of 
educated commonsense. What we should tell each individual patient should reflect the study 
result noted above: Respect for patients’ autonomy should prompt women’s health care 
providers to share their knowledge of the harms of endocrine-disrupting chemicals with 
those at risk.55
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Providers as Educators and Advocates
Given the ubiquity of industrial chemicals in our environment, what can providers do to 
decrease their patients’ exposures? Although counsel provided to individual patients about 
the avoidance of specific toxins through consumer action may help the individual, it is 
limited in its ability to address the larger problem. This is particularly true in light of the 
disparate impact that environmental toxins have on disadvantaged women and families, and 
with environmental injustices that increase health disparities.15 Midwives are encouraged to 
act as “change agents” to promote policies and regulations that protect the environment.14
History has shown that regulatory changes can have an impact upon the levels of toxic 
chemicals in humans. When lead was phased out of gasoline and paint in the early 1970s, 
lead levels in the blood of Americans dropped precipitously.4 In 2006, PBDEs were banned 
in the state of California, and in 2013 research demonstrated lower levels in pregnant women 
over time.68 Clearly, removing chemicals from use can reliably and measurably remove 
them from humans, with the caveat that some pollutants are persistent (eg, many 
perfluorinated compounds and polychlorinated biphenyls), and are slower to be removed 
from the environment and our bodies. However, chemicals that are removed from industrial 
use after health harms are found may be replaced with newer substances that also carry 
endocrine-disrupting or other health dangers.64,65 Not surprisingly, such substitutions 
suggest moving to a precautionary approach to regulation, that is, at a minimum, testing 
chemicals for health effects prior to their use in commercial products such as toys or baby 
equipment. This approach is similar to that of the European Union, and the FDA’s approach 
to pharmaceuticals. Ideally, chemicals with the potential to harm human health would not 
make their way into our food systems and homes prior to thorough testing for endocrine or 
other health effects. Recent legislation intended to reform the Toxic Substances Control Act 
is in conference committee to reconcile House and Senate versions of the bill; whether the 
final legislation will have much impact on the current regulatory framework is not yet 
known.69
Health care providers are used to thinking about behavioral changes that patients can make 
to improve their health. With toxic environmental exposure, however, individuals often must 
rely for protection upon on broad regulation or social consensus. For example, science 
provided evidence for tobacco’s dangers; social pressure has made smoking both less 
desirable and more highly regulated. For environmental concerns that cannot be avoided 
through simple individual actions (eg, exposures in public settings, contamination of food 
systems by persistent organic pollutants, exposure to fracking in residential neighborhoods), 
educated patients can contact their elected representatives and policymakers to seek 
regulatory change.
Women’s health care providers are well positioned to provide the impetus for action on 
research, regulation, and structural change, and history has shown the efficacy of citizen 
advocacy groups. The March of Dimes has outlasted its original mission of combating polio 
to become an advocate for maternal and child health. The Back to Sleep (now Safe to Sleep) 
initiative by the American Academy of Pediatrics predated some of the definitive research 
into sudden infant death syndrome, providing a fine example of wise precautionary action. 
Midwives, acting locally and focusing as a group on local concerns, can brainstorm about 
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resources and share ideas about communicating essentials to their patients. One possible 
action would be to lobby local businesses or government to open a farmers’ market in a 
neighborhood devoid of stores selling affordable pesticide-free produce. If midwives identify 
a local toxic exposure of concern, such as lead in the municipal water supply, they can both 
provide counsel to individual women, but also work for local regulatory change by 
contacting their elected representatives or local media. Midwives, acting nationally as 
lobbyists, letter writers, and educators for congressional representatives, can have an impact 
that serves the welfare of women everywhere.
SUMMARY
Many chemicals present in consumer products, the US food supply, and the environment are 
suspected endocrine disruptors. Given the importance of endocrine function in reproduction 
and healthy offspring, evidence of endocrine disruption is of prime concern to women’s 
health care providers. Some adverse health trends may or may not be related to 
environmental toxins, but the relevant basic science and epidemiology are of significant 
concern, warranting an approach based on the precautionary principle.
Wise counsel for the women whose health is our concern is perhaps our hardest task. As 
noted above, overly busy schedules and concern about provoking unhelpful fears often are 
obstacles to conveying important information. But the special ties between reproductive 
health care providers and the women they care for ought to be fertile ground for creative, 
educated, thoughtful and protective guidance and support.
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Appendix
APPENDIX:
Resources for further information
Resource Type of information available Available at: internet/telephone
CDC Guidance on lead 
in pregnancy
In-depth review of the impact and 
management of lead exposure in 
pregnancy.
http://www.cdc.gov/nceh/lead/publications/
LeadandPregnancy2010.pdf
Although lead affects fetuses and 
children are primarily through direct 
toxic effect, it can also cause endocrine 
disruption.
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Resource Type of information available Available at: internet/telephone
The Collaborative on 
Health and the 
Environment (CHE)
CHE is a nonpartisan organization with a 
mission to strengthen the science 
dialogue on environmental factors 
impacting human health and to facilitate 
prevention-oriented efforts to address 
environmental health concerns.
http://www.healthandenvironment.org/
The website has a searchable database 
that summarizes links between chemical 
contaminants and approximately 180 
human diseases or conditions. Searches 
can be made by disease or toxicant.
CHE Toxicant & Disease database http://
www.healthandenvironment.org/tddb/
Frequent webinars present current 
research on a variety of topics related to 
the impact of the environment on health.
The Endocrine 
Disruption Exchange 
(TEDX) (includes List of 
Possible Endocrine 
Disruptors)
The TEDX List of Potential Endocrine 
Disruptors is a database of nearly 1000 
chemicals with the potential to affect 
endocrine systems.
http://www.endocrinedisruption.org/
Interactive timeline describes critical 
windows of development of various 
organ systems.
http://www.endocrinedisruption.org/prenatal-
origins-of-endocrine-disruption/critical-
windows-of-development/timeline-test/
Environmental Working 
Group (& Skin Deep 
website)
EWG’s website has news and 
commentary on current environmental 
issues and consumer information.
http://www.ewg.org/
EWG’s Skin Deep is a searchable 
database of personal care products rated 
by the toxicity of their ingredients.
http://www.ewg.org/skindeep/
The Occupational Safety 
and Health 
Administration (OHSA)
OSHA is a federal agency that sets and 
enforces federal safety and health 
standards for the workplace.
(800) 321–6742 or www.osha.gov
NIH National Library of 
Medicine Household 
Products Database
A database of health and safety 
information regarding household 
products is searchable by product, 
ingredients, manufacturer, and health 
effects; includes information about 
contents of products, potential health 
effects, safety and handling.
http://householdproducts.nlm.nih.gov/
products.htm
Pediatric
Environmental Health 
Specialty Unit (PEHSU) 
network:
The PEHSU network has clinicians 
available for in-person patient or 
provider telephone consultation 
regarding any environmental exposures 
relevant to pregnancy and childhood.
http://www.pehsu.net
PEHSU-East National Office (Federal 
Regions 1–5): Tel: (888) 227–1785 (Toll 
Free)
PEHSU-West National Office (Federal 
Regions 6–10): Tel: (844) PEHSU-W9 or 
(844) 734–7899 (Toll Free)
UCSF/ Western States PEHSU: 
1-866-827-3478.
The website has patient and provider 
factsheets on many topics of interest.
University of California 
San Francisco's Program 
on Reproductive Health 
and the Environment 
(PRHE)
PRHE has an extensive website with 
information specifically for patients and 
families (available as downloadable 
brochures) and many resources and links 
for clinicians and researchers. 
Information for clinicians includes links 
to environmental history forms.
http://prhe.ucsf.edu/prhe/families.html
Resources for clinicians: http://prhe.ucsf.edu/
prhe/clinicalresources.html
Abbreviations: CDC, Centers for Disease Control and Prevention; NIH, National Institutes of Health.
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Quick Points
• Virtually every pregnant woman in the US has at least 43 different 
environmental chemicals in her bloodstream.
• Common chemicals such as BPA, phthalates, flame retardants, and 
perfluorinated compounds can act as endocrine disruptors (chemicals which 
interfere with normal hormonal activity).
• Troubling health trends, including increases in abnormal neurodevelopment 
and infertility, may or may not be related to endocrine-disrupting chemicals, 
but the basic science & epidemiology are of enough concern to suggest 
employment of the “precautionary principle.” That is, when the health of 
humans and the environment is at stake, it may not be necessary to wait for 
scientific certainty to take protective action.
• Clinicians can and should educate women and advocate for safer chemical 
policies.
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 B
PA
-li
ke
 a
dd
iti
v
e.
 M
ic
ro
w
av
in
g 
in
 p
la
sti
c 
in
cr
ea
se
s t
he
 le
ac
hi
ng
 o
f c
he
m
ic
al
s 
in
to
 fo
od
. M
ic
ro
w
av
e 
in
 g
la
ss
 c
on
ta
in
er
s o
r c
er
am
ic
 b
ow
ls.
 U
se
 a
 p
la
te
 to
 c
ov
er
 a
 d
ish
 ra
th
er
 th
an
 p
la
sti
c 
w
ra
p.
D
oe
s y
ou
r w
at
er
 c
om
e 
fro
m
 a
 w
el
l?
W
el
l w
at
er
 s
ho
ul
d 
be
 re
ste
d 
ro
ut
in
el
y 
fo
r c
on
ta
m
in
an
ts.
If 
yo
ur
 h
ou
se
 is
 o
ld
, d
oe
s i
t h
av
e 
le
ad
 p
ip
es
?
R
un
 th
e 
ta
p 
fo
r 6
0 
se
co
nd
s t
o 
flu
sh
 o
ut
 si
tti
ng
 w
at
er
.
C
he
m
ic
al
s i
n 
pe
rs
on
al
 ca
re
 p
ro
du
ct
s, 
fr
ag
ra
nc
es
, a
nd
 h
ou
se
ho
ld
 c
le
an
er
s 
m
a
y 
be
 h
ar
m
fu
l t
o 
pr
eg
na
nt
 w
o
m
en
 o
r 
fe
tu
se
s.
Th
es
e 
pr
od
uc
ts 
m
ay
 c
on
ta
in
 c
he
m
ic
al
s s
uc
h 
as
 p
ht
ha
la
te
s w
hi
ch
 a
re
 th
ou
gh
t t
o 
ca
us
e 
de
v
el
op
m
en
ta
l p
ro
bl
em
s f
or
 
gr
ow
in
g 
fe
tu
se
s.
D
o 
yo
u 
us
e 
fra
gr
an
t p
er
so
na
l c
ar
e 
pr
od
uc
ts 
su
ch
 a
s p
er
fu
m
e,
 b
od
y 
sp
ra
y, 
lo
tio
n,
 
o
r 
sh
am
po
o/
co
nd
iti
on
er
?
U
se
 fe
w
er
 p
ro
du
ct
s, 
an
d 
pu
rc
ha
se
 fr
ag
ra
nc
e-
fre
e 
if 
po
ss
ib
le
.
D
o 
yo
u 
us
e 
ch
em
ic
al
s a
t h
om
e 
or
 w
o
rk
 fo
r c
le
an
in
g 
or
 sc
en
t?
Pr
ac
tic
e 
sa
fe
 h
an
dl
in
g 
te
ch
ni
qu
es
 if
 y
ou
 h
av
e 
to
 u
se
 s
tr
on
g 
ch
em
ic
al
s. 
Tr
y 
to
 u
se
 le
ss
-to
xi
c 
al
te
rn
at
iv
es
 fo
r c
le
an
in
g 
su
ch
 a
s v
in
eg
ar
,
 
so
ap
, a
nd
 b
ak
in
g 
so
da
. A
v
o
id
 a
ir 
fre
sh
en
er
s a
nd
 sc
en
te
d 
ca
nd
le
s.
a S
ou
rc
e:
 G
re
at
 L
ak
es
 C
en
te
r f
or
 C
hi
ld
re
n’
s E
nv
iro
nm
en
ta
l H
ea
lth
 (R
eg
io
n 
5 
PE
H
SU
), a
da
pte
d w
ith
 w
ith
 pe
rm
iss
ion
 fr
om
 Su
san
 B
uc
ha
na
n, 
M
D 
an
d a
v
ai
la
bl
e 
fro
m
: h
ttp
://
w
w
w.
u
ic
.e
du
/sp
h/
gl
ak
es
/
ch
ild
re
ns
he
al
th
/d
ow
n
lo
ad
s/E
nv
%
20
hi
sto
ry
%
20
fo
rm
%
20
10
–2
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Ta
bl
e 
3.
Su
gg
es
te
d 
ac
tio
ns
 to
 d
ec
re
as
e 
in
di
v
id
ua
l e
x
po
su
re
 to
 e
nd
oc
rin
e 
di
sr
up
tin
g 
ch
em
ic
al
s
G
oa
l o
f 
A
ct
io
n
Si
m
pl
e S
te
ps
Ex
pe
ct
ed
 O
ut
co
m
e
Av
o
id
 e
at
in
g 
o
r 
dr
in
ki
ng
 
to
xi
ns
W
as
h 
ha
nd
s w
ith
 p
la
nt
-b
as
ed
 so
ap
 p
rio
r t
o 
ea
tin
g,
 a
s t
ox
in
s p
re
se
nt
 o
n 
ha
nd
s m
ay
 b
e 
or
al
ly
 in
ge
ste
d.
D
ec
re
as
ed
 c
on
ta
m
in
at
io
n 
of
 h
an
ds
 
w
ith
 B
PA
,61
 
ph
th
al
at
es
,62
,
63
 
an
d 
ot
he
r 
po
te
nt
ia
l t
ox
in
s
Ch
oo
se
 o
rg
an
ic
 p
ro
du
ce
 a
nd
 w
as
h 
pr
od
uc
e 
to
 re
m
ov
e 
pe
sti
ci
de
 re
sid
ue
.
N
OT
E:
 If
 o
rg
an
ic
 is
 to
o 
ex
pe
ns
iv
e,
 c
ho
os
e 
ite
m
s f
ro
m
 th
e 
“C
le
an
 F
ift
ee
n”
 li
st.
 h
ttp
://
w
w
w.
ew
g.
or
g/
fo
od
ne
w
s/c
le
an
fif
te
en
lis
t.p
hp
Le
ss
 p
es
tic
id
e 
re
sid
ue
60
Av
o
id
 p
ro
ce
ss
ed
 fo
od
s, 
in
cl
ud
in
g 
fa
st
 fo
od
, w
hi
ch
 a
re
 o
fte
n 
ex
po
se
d 
to
 p
la
sti
c 
du
rin
g 
m
an
uf
ac
tu
re
 o
r s
to
ra
ge
. F
at
ty
 fo
od
s a
nd
 m
ea
t a
re
 m
or
e 
lik
el
y 
to
 c
on
ta
in
 fl
am
e 
re
ta
rd
an
ts.
Le
ss
 e
x
po
su
re
 to
 p
la
sti
ci
ze
rs
, f
la
m
e 
re
ta
rd
an
ts5
8,
59
Li
m
it 
fo
od
s h
ig
h 
in
 a
ni
m
al
 fa
t. 
Pe
rs
ist
en
t o
rg
an
ic
 p
ol
lu
ta
nt
s a
re
 fa
t s
ol
ub
le
, a
nd
 m
ay
 b
e 
fo
un
d 
in
 th
e 
fo
od
 c
ha
in
. F
la
m
e 
re
ta
rd
an
ts 
ha
v
e 
a 
ha
lf-
lif
e 
of
 1
–3
 y
ea
rs
 in
 h
um
an
 fa
t.
Lo
w
er
 e
x
po
su
re
 to
 p
er
sis
te
nt
 o
rg
an
ic
 
po
llu
ta
nt
s4
,
39
Av
o
id
 fo
od
s w
ith
 su
bs
ta
nt
ia
l p
la
sti
c 
co
nt
ac
t, 
pa
rti
cu
la
rly
 if
 th
e 
fo
od
 is
 w
et
, i
nc
lu
di
ng
 c
an
ne
d 
fo
od
s, 
so
da
s, 
w
et
 fo
od
s i
n 
pl
as
tic
 p
ou
ch
es
 o
r 
bo
xe
s.
Lo
w
er
 e
x
po
su
re
 to
 B
PA
, p
ht
ha
la
te
s, 
an
d 
ot
he
r p
la
sti
ci
ze
rs
58
,
59
Av
o
id
 p
la
sti
cs
 th
ou
gh
t t
o 
ha
v
e 
m
o
re
 h
ea
lth
 ri
sk
s i
nc
lu
di
ng
 P
V
C,
 p
ol
ys
ty
re
ne
, a
nd
 p
ol
yc
ar
bo
na
te
 (l
ab
ele
d w
ith
 pl
ast
ic 
rec
yc
lin
g 
nu
m
be
rs
 3
, 6
, 
an
d 
7,
 re
sp
ec
tiv
el
y).
 Pl
ast
ics
 la
be
led
 "B
PA
-fr
ee
" m
ay
 c
on
ta
in
 o
th
er
 p
la
sti
ci
ze
rs
 su
ch
 a
s b
isp
he
no
l S
 th
at
 a
re
 a
lso
 th
ou
gh
t t
o 
ha
v
e 
en
do
cr
in
e-
di
sr
up
tin
g 
pr
op
er
tie
s. 
St
ai
nl
es
s s
te
el
 a
nd
 g
la
ss
 a
re
 c
on
sid
er
ed
 sa
fe
r a
lte
rn
at
iv
es
.
Lo
w
er
 e
x
po
su
re
 to
 B
PA
, p
ht
ha
la
te
s, 
an
d 
ot
he
r p
la
sti
ci
ze
rs
63
–
66
D
o 
no
t m
ic
ro
w
av
e 
in
 p
la
sti
c.
 H
ea
tin
g 
in
cr
ea
se
s l
ea
ch
in
g 
of
 c
he
m
ic
al
s, 
es
pe
ci
al
ly
 w
ith
 fa
tty
 fo
od
s. 
U
se
 a
 p
ap
er
 to
w
el
 o
r g
la
ss
 li
d 
to
 c
ov
er
 fo
od
 
in
 th
e 
m
ic
ro
w
av
e.
Lo
w
er
 e
x
po
su
re
 to
 B
PA
, p
ht
ha
la
te
s, 
an
d 
ot
he
r p
la
sti
ci
ze
rs
63
,
66
Av
o
id
 to
xi
ns
 
in
 th
e 
ho
m
e.
Li
m
it 
pe
sti
ci
de
 a
nd
 so
lv
en
t u
se
 in
 h
om
e.
 C
le
an
 w
ith
 so
ap
 a
nd
 v
in
eg
ar
.
 
U
se
 b
ak
in
g 
so
da
 fo
r a
nt
s. 
K
ee
p 
co
un
te
rs
 c
le
an
. U
se
 in
te
gr
at
ed
 p
es
t 
m
an
ag
em
en
t s
tra
te
gi
es
 (a
 pr
oc
ess
 in
ten
de
d t
o a
dd
res
s p
est
 pr
ob
lem
s w
hil
e m
ini
mi
zin
g r
isk
s t
o p
eo
ple
 an
d t
he
 en
v
iro
nm
en
t b
y 
m
in
im
iz
in
g 
ch
em
ic
al
 u
se
 w
hi
le
 ta
ki
ng
 a
dv
an
ta
ge
 o
f n
at
ur
al
 in
hi
bi
to
rs
 o
f p
es
t a
ct
iv
ity
) i
n t
he
 ga
rd
en
.
Se
e
ht
tp
://
w
w
w.
ip
m
.u
cd
av
is.
ed
u/
PM
G
/m
en
u.
ho
m
eg
ar
de
n.
ht
m
l
Le
ss
 p
es
tic
id
e 
ex
po
su
re
D
ec
re
as
e 
ho
us
e 
du
st,
 w
hi
ch
 m
ay
 c
on
ta
in
 to
xi
c 
ch
em
ic
al
s. 
Ta
ke
 s
ho
es
 o
ff 
ou
tsi
de
. D
us
t, 
da
m
p 
m
op
, o
r v
ac
u
u
m
 (w
ith
 a 
HE
PA
 fi
lte
r) 
tw
ice
 
w
ee
kl
y 
(da
ily
 fo
r h
igh
 ri
sk
 du
st 
or 
cra
w
lin
g 
ba
by
). T
he
se 
ste
ps
 ar
e e
sp
ec
ial
ly 
im
po
rta
nt 
wh
en
 du
st 
is 
lik
el
y 
to
 b
e 
hi
gh
 ri
sk
: t
o 
ha
v
e 
to
xi
ns
, s
uc
h 
as
 in
 a
gr
ic
ul
tu
ra
l a
re
as
 a
nd
 u
rb
an
 n
ei
gh
bo
rh
oo
ds
, o
r w
he
n 
th
e 
pa
tie
nt
 o
r h
ou
se
ho
ld
 m
em
be
r w
o
rk
s i
n 
oc
cu
pa
tio
n 
w
ith
 p
es
tic
id
es
, s
ol
ve
n
ts
, 
le
ad
, o
r o
th
er
 to
xi
ns
.
Le
ss
 e
x
po
su
re
 to
 le
ad
, f
la
m
e 
re
ta
rd
an
ts,
 p
es
tic
id
es
, p
ht
ha
la
te
s, 
an
d 
o
th
er
 to
xi
c 
ch
em
ic
al
s, 
as
 w
el
l a
s 
al
le
rg
en
s a
nd
 e
nd
ot
ox
in
.39
,
67
G
et
 ri
d 
of
 o
ld
 fo
am
 fu
rn
itu
re
 o
r r
ep
la
ce
 th
e 
fo
am
 in
 th
e 
cu
sh
io
ns
. F
la
m
e 
re
ta
rd
an
ts 
ar
e 
w
o
rs
t i
n 
pr
e-
20
05
 fo
am
. T
he
 ri
sk
 ap
pe
ar
s t
o 
be
 h
ig
he
r i
f 
th
e 
fo
am
 is
 c
ru
m
bl
in
g.
 If
 fu
rn
itu
re
 c
an
ť b
e r
ep
lac
ed
, d
am
p 
m
op
 o
r v
ac
u
u
m
 w
ith
 a
 H
EP
A
 fi
lte
r.
N
OT
E:
 F
o
am
 c
u
sh
io
ns
 c
an
 b
e 
re
pl
ac
ed
 b
y 
co
nt
ac
tin
g 
Sa
fe
r F
o
am
 E
xc
ha
ng
e 
at
 h
ttp
://
gr
ee
ns
ci
en
ce
po
lic
y.
o
rg
/re
sp
on
sib
le
-fu
rn
itu
re
-d
isp
os
al
/
#e
x
ch
an
ge
Le
ss
 e
x
po
su
re
 to
 fl
am
e 
re
ta
rd
an
ts.
39
,
67
Av
o
id
 to
xi
ns
 
o
n
 y
o
u
r 
sk
in
.
Av
o
id
 c
ar
bo
nl
es
s r
ec
ei
pt
s. 
D
on
ť t
ak
e 
re
ce
ip
t i
f y
ou
 d
on
ť n
ee
d 
it.
 C
as
hi
er
s s
ho
ul
d 
we
ar
 g
lo
v
es
 w
he
n 
w
o
rk
in
g 
w
ith
 re
ce
ip
ts 
an
d 
w
as
h 
ha
nd
s 
th
or
ou
gh
ly
 p
rio
r t
o 
ea
tin
g.
 M
an
y 
re
ce
ip
ts 
co
nt
ai
n 
ph
th
al
at
es
 o
r B
PA
.
D
ec
re
as
ed
 u
rin
ar
y 
BP
A
 le
v
el
s.6
1
B
e 
th
ou
gh
tfu
l a
bo
ut
 b
od
y 
pr
od
uc
ts:
 av
o
id
 p
ht
ha
la
te
s (
oft
en
 lis
ted
 as
 fr
ag
ran
ce
), p
ara
be
ns
, a
nd
 tr
icl
os
an
. R
isk
 st
rat
ify
 (i
ťs 
mo
re 
im
po
rta
nt 
to 
av
o
id
 th
es
e 
du
rin
g 
“w
in
do
w
s 
o
f s
us
ce
pt
ib
ili
ty
,
”
 
su
ch
 a
s p
re
gn
an
cy
,
 
la
ct
at
io
n,
 in
fa
n
cy
,
 
pu
be
rty
.
 
Ch
em
ic
al
s m
ea
nt
 to
 st
ay
 o
n 
th
e 
sk
in
 m
ay
 re
su
lt 
in
 h
ig
he
r d
os
es
 th
an
 th
os
e 
w
as
he
d 
of
f.
N
OT
E:
 O
nl
in
e 
re
so
ur
ce
s i
nc
lu
de
 th
e 
Sk
in
 D
ee
p 
da
ta
ba
se
 fr
om
 w
w
w
.
ew
g.
or
g 
an
d 
th
e 
Ca
lif
or
ni
a 
Sa
fe
 C
os
m
et
ic
s P
ro
gr
am
 D
at
ab
as
e 
ht
tp
s:/
/
sa
fe
co
sm
et
ic
s.c
dp
h.
ca
.g
ov
/se
ar
ch
/
D
ec
re
as
ed
 ex
po
su
re
 to
 p
ht
ha
la
te
s, 
pa
ra
be
ns
, a
nd
 o
th
er
 e
nd
oc
rin
e-
di
sr
up
tin
g 
ch
em
ic
al
s.2
,
3,
77
4
A
bb
re
v
ia
tio
ns
: B
PA
, b
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he
no
l A
; H
EP
A
, H
ig
h-
ef
fic
ie
nc
y 
pa
rti
cu
la
te
 a
ir;
 P
V
C,
 p
ol
yv
in
yl
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hl
or
id
e.
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